Published :
Tables : 46
Figures : 43
Category : Healthcare
No. of Pages : 216
Report Code : HC-U3321
Multimodal Imaging Market is poised to value over CAGR of over 4.3% during the forecast period 2022 to 2028. Advancements in diagnostic imaging technology, broadened range of applications in multimodal imaging systems, increased research funding, favourable reimbursement policies, increased research and development in radiotracers and rise in the insurance coverage are the key driving factors of the market. Multimodal imaging is mainly used for drug discovery and in non-invasive and invasive surgical procedures which shall augment the multimodal imaging market growth. The optical fluorescence imaging has garnered a huge demand as it is very efficient in providing real-time images. This imaging method is used extensively for studying molecular events which is why it is often deployed in surgeries that require image guidance. All these factors shall bolster the growth of the market. Market Segmentation: By Technology • PET-CT • SPECT-CT • PET-MR • OCT • Trimodal By Application • Cardiology • Brain and Neurology • Ophthalmology • Oncology • Others By End User • Hospitals • Diagnostic Imaging Centers • Other End Users By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa The market is classified into technology, application, end user and region. The technology segment is fragmented into PET-CT, SPECT-CT, PET-MR, OCT and Trimodal. The PET-CT systems held the largest multimodal imaging market share owing to the rising insistence for accurate and early diagnosis of cancer, increased clinical evidence for detecting Alzheimer’s disease as early as possible. The application segment is divided into cardiology, brain and neurology, ophthalmology, oncology and other applications. The oncology segment is predicted to dominate the market owing to the rising incidence of cancer across the world, extensive usage of multimodal system for diagnosing tumors. The end user segment is bifurcated into diagnostic imaging centres, hospitals and other end users. The hospital segment subjugated the market owing to increased installations of advanced imaging systems such as SPECT-CT and PET-CT, increased demand for diagnostic processes that are non-invasive in nature. Regional Analysis: The North America region is expected to lead the market owing to the integration of advanced multimodal imaging systems in hospital settings, improves reimbursement scenario, increased financial assistance pertaining to the novel imaging systems. However, the Asia Pacific region is predicted to grow at a substantial rate during the forecast period and this can be credited to improvements in the healthcare infrastructure, increasing patient population and improving insurance coverage policies. Competitive Landscape: Some of the prominent market players are GE Healthcare, Siemens Healthineers, Koninklijke Philips N.V., Canon Inc., United Imaging Healthcare Co. Ltd., Mediso Medical Imaging Systems Kft, Neusoft Medical Systems Co. Ltd., Infraredx Inc., Spectrum Dynamics Medical, Topcon Corporation, Heidelberg Engineering, Carl Zeiss AG, Optovue Inc., Nidek Co., Ltd., Optos Plc (UK) (a part of Nikon Corporation), Kowa Company, Ltd. FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the global multimodal imaging market by technology, by application, by end user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Advancements in diagnostic imaging technology, broadened range of applications in multimodal imaging systems, increased research funding, favourable reimbursement policies, increased research and development in radiotracers and rise in the insurance coverage are the key driving factors of the market. Multimodal imaging is mainly used for drug discovery and in non-invasive and invasive surgical procedures which shall augment the multimodal imaging market growth. The optical fluorescence imaging has garnered a huge demand as it is very efficient in providing real-time images. This imaging method is used extensively for studying molecular events which is why it is often deployed in surgeries that require image guidance. All these factors shall bolster the growth of the market.
Market Segmentation:
By Technology • PET-CT • SPECT-CT • PET-MR • OCT • Trimodal By Application • Cardiology • Brain and Neurology • Ophthalmology • Oncology • Others By End User • Hospitals • Diagnostic Imaging Centers • Other End Users By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa
The market is classified into technology, application, end user and region. The technology segment is fragmented into PET-CT, SPECT-CT, PET-MR, OCT and Trimodal. The PET-CT systems held the largest multimodal imaging market share owing to the rising insistence for accurate and early diagnosis of cancer, increased clinical evidence for detecting Alzheimer’s disease as early as possible. The application segment is divided into cardiology, brain and neurology, ophthalmology, oncology and other applications. The oncology segment is predicted to dominate the market owing to the rising incidence of cancer across the world, extensive usage of multimodal system for diagnosing tumors. The end user segment is bifurcated into diagnostic imaging centres, hospitals and other end users. The hospital segment subjugated the market owing to increased installations of advanced imaging systems such as SPECT-CT and PET-CT, increased demand for diagnostic processes that are non-invasive in nature.
Regional Analysis:
The North America region is expected to lead the market owing to the integration of advanced multimodal imaging systems in hospital settings, improves reimbursement scenario, increased financial assistance pertaining to the novel imaging systems. However, the Asia Pacific region is predicted to grow at a substantial rate during the forecast period and this can be credited to improvements in the healthcare infrastructure, increasing patient population and improving insurance coverage policies.
Competitive Landscape:
Some of the prominent market players are GE Healthcare, Siemens Healthineers, Koninklijke Philips N.V., Canon Inc., United Imaging Healthcare Co. Ltd., Mediso Medical Imaging Systems Kft, Neusoft Medical Systems Co. Ltd., Infraredx Inc., Spectrum Dynamics Medical, Topcon Corporation, Heidelberg Engineering, Carl Zeiss AG, Optovue Inc., Nidek Co., Ltd., Optos Plc (UK) (a part of Nikon Corporation), Kowa Company, Ltd.
FutureWise Key Takeaways:
• Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the global multimodal imaging market by technology, by application, by end user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions
Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Multimodal Imaging Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Multimodal Imaging Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Multimodal Imaging Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Multimodal Imaging Market, By Technology Historical Analysis 2016 to 2020 and Forecast 2022-2028 (USD million) 7.1 PET-CT 7.2 SPECT-CT 7.3 PET-MR 7.4 OCT 7.5 Trimodal 8. Multimodal Imaging Market, By Application Historical Analysis 2016 to 2020 and Forecast 2022-2028 (USD million) 8.1 Cardiology 8.2 Brain and Neurology 8.3 Ophthalmology 8.4 Oncology 8.5 Others 9. Multimodal Imaging Market, By End User Historical Analysis 2016 to 2020 and Forecast 2022-2028 (USD million) 9.1 Hospitals 9.2 Diagnostic Imaging Centers 9.3 Other End Users 10. North America Multimodal Imaging Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2022-2028 11. Latin America Multimodal Imaging Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Brazil 11.2.2. Venezuela 11.2.3. Argentina 11.2.4. Rest of Latin America 11.3. Market Size (USD Million) Forecast for Latin America 2022-2028 12. Europe Multimodal Imaging Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Rest of Europe 12.3. Market Size (USD Million) Forecast for Europe 2022-2028 13. Asia Pacific Multimodal Imaging Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Japan 13.2.2. China 13.2.3. India 13.2.4. Australia and New Zealand 13.2.5. ASEAN 13.2.6. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 14. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. GCC 14.2.2. Israel 14.2.3. South Africa 14.2.4. Rest of MEA 14.3. Market Size (USD Million) Forecast for MEA 2022-2028 15. Market Share Analysis and Competitive Landscape 15.1. Global Landscape - Key Players, Revenue and Presence 15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 15.3. Global Emerging Companies 15.4. North America - Market Share Analysis and Key Regional Players 15.5. Europe - Market Share Analysis and Key Regional Players 15.6. Asia Pacific - Market Share Analysis and Key Regional Players 15.7. Global Key Player - Growth Matrix 16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 16.1 Koninklijke Philips N.V. 16.1.1. Company Overview (HQ, Business Segments, Employee Strength) 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2 Canon Inc. 16.2.1. Company Overview (HQ, Business Segments, Employee Strength) 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3 United Imaging Healthcare Co. Ltd. 16.3.1. Company Overview (HQ, Business Segments, Employee Strength) 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4 Siemens 16.4.1. Company Overview (HQ, Business Segments, Employee Strength) 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5 Mediso Medical Imaging Systems Kft 16.5.1. Company Overview (HQ, Business Segments, Employee Strength) 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6 Neusoft Medical Systems Co. Ltd. 16.6.1. Company Overview (HQ, Business Segments, Employee Strength) 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7 Infraredx Inc. 16.7.1. Company Overview (HQ, Business Segments, Employee Strength) 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8 Spectrum Dynamics Medical 16.8.1. Company Overview (HQ, Business Segments, Employee Strength) 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9 Topcon Corporation 16.9.1. Company Overview (HQ, Business Segments, Employee Strength) 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10 GE Healthcare 16.10.1. Company Overview (HQ, Business Segments, Employee Strength) 16.10.2. Product Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 16.11 Heidelberg Engineering 16.11.1. Company Overview (HQ, Business Segments, Employee Strength) 16.11.2. Product Portfolio 16.11.3. SWOT Analysis 16.11.4. Financial Overview 16.11.5. Strategic Overview 16.12 Carl Zeiss AG 16.12.1. Company Overview (HQ, Business Segments, Employee Strength) 16.12.2. Product Portfolio 16.12.3. SWOT Analysis 16.12.4. Financial Overview 16.12.5. Strategic Overview 16.13 Optovue Inc. 16.13.1. Company Overview (HQ, Business Segments, Employee Strength) 16.13.2. Product Portfolio 16.13.3. SWOT Analysis 16.13.4. Financial Overview 16.13.5. Strategic Overview 16.14 Nidek Co., Ltd. 16.14.1. Company Overview (HQ, Business Segments, Employee Strength) 16.14.2. Product Portfolio 16.14.3. SWOT Analysis 16.14.4. Financial Overview 16.14.5. Strategic Overview 16.16 Optos Plc (UK) (a part of Nikon Corporation) 16.16.1. Company Overview (HQ, Business Segments, Employee Strength) 16.16.2. Product Portfolio 16.16.3. SWOT Analysis 16.16.4. Financial Overview 16.16.5. Strategic Overview 16.16 Kowa Company Ltd. 16.16.1. Company Overview (HQ, Business Segments, Employee Strength) 16.16.2. Product Portfolio 16.16.3. SWOT Analysis 16.16.4. Financial Overview 16.16.5. Strategic Overview 17. Pre and Post COVID-19 Impact 17.1. Positive influence on the healthcare industry 17.2. The financial disruption of the manufacturing sector 17.3. Impact of COVID-19 on emerging companies 17.4. Significant mandates in the regulations initiated by healthcare administrations 17.5. The overall economic slowdown of the developing and developed nations 18. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Multimodal Imaging Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Multimodal Imaging Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Multimodal Imaging Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Multimodal Imaging Market, By Technology Historical Analysis 2016 to 2020 and Forecast 2022-2028 (USD million) 7.1 PET-CT 7.2 SPECT-CT 7.3 PET-MR 7.4 OCT 7.5 Trimodal 8. Multimodal Imaging Market, By Application Historical Analysis 2016 to 2020 and Forecast 2022-2028 (USD million) 8.1 Cardiology 8.2 Brain and Neurology 8.3 Ophthalmology 8.4 Oncology 8.5 Others 9. Multimodal Imaging Market, By End User Historical Analysis 2016 to 2020 and Forecast 2022-2028 (USD million) 9.1 Hospitals 9.2 Diagnostic Imaging Centers 9.3 Other End Users
10. North America Multimodal Imaging Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2022-2028
11. Latin America Multimodal Imaging Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Brazil 11.2.2. Venezuela 11.2.3. Argentina 11.2.4. Rest of Latin America 11.3. Market Size (USD Million) Forecast for Latin America 2022-2028
12. Europe Multimodal Imaging Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Rest of Europe 12.3. Market Size (USD Million) Forecast for Europe 2022-2028
13. Asia Pacific Multimodal Imaging Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Japan 13.2.2. China 13.2.3. India 13.2.4. Australia and New Zealand 13.2.5. ASEAN 13.2.6. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
14. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. GCC 14.2.2. Israel 14.2.3. South Africa 14.2.4. Rest of MEA 14.3. Market Size (USD Million) Forecast for MEA 2022-2028
15. Market Share Analysis and Competitive Landscape 15.1. Global Landscape - Key Players, Revenue and Presence 15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 15.3. Global Emerging Companies 15.4. North America - Market Share Analysis and Key Regional Players 15.5. Europe - Market Share Analysis and Key Regional Players 15.6. Asia Pacific - Market Share Analysis and Key Regional Players 15.7. Global Key Player - Growth Matrix
16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 16.1 Koninklijke Philips N.V. 16.1.1. Company Overview (HQ, Business Segments, Employee Strength) 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2 Canon Inc. 16.2.1. Company Overview (HQ, Business Segments, Employee Strength) 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3 United Imaging Healthcare Co. Ltd. 16.3.1. Company Overview (HQ, Business Segments, Employee Strength) 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4 Siemens 16.4.1. Company Overview (HQ, Business Segments, Employee Strength) 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5 Mediso Medical Imaging Systems Kft 16.5.1. Company Overview (HQ, Business Segments, Employee Strength) 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6 Neusoft Medical Systems Co. Ltd. 16.6.1. Company Overview (HQ, Business Segments, Employee Strength) 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7 Infraredx Inc. 16.7.1. Company Overview (HQ, Business Segments, Employee Strength) 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8 Spectrum Dynamics Medical 16.8.1. Company Overview (HQ, Business Segments, Employee Strength) 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9 Topcon Corporation 16.9.1. Company Overview (HQ, Business Segments, Employee Strength) 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10 GE Healthcare 16.10.1. Company Overview (HQ, Business Segments, Employee Strength) 16.10.2. Product Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 16.11 Heidelberg Engineering 16.11.1. Company Overview (HQ, Business Segments, Employee Strength) 16.11.2. Product Portfolio 16.11.3. SWOT Analysis 16.11.4. Financial Overview 16.11.5. Strategic Overview 16.12 Carl Zeiss AG 16.12.1. Company Overview (HQ, Business Segments, Employee Strength) 16.12.2. Product Portfolio 16.12.3. SWOT Analysis 16.12.4. Financial Overview 16.12.5. Strategic Overview 16.13 Optovue Inc. 16.13.1. Company Overview (HQ, Business Segments, Employee Strength) 16.13.2. Product Portfolio 16.13.3. SWOT Analysis 16.13.4. Financial Overview 16.13.5. Strategic Overview 16.14 Nidek Co., Ltd. 16.14.1. Company Overview (HQ, Business Segments, Employee Strength) 16.14.2. Product Portfolio 16.14.3. SWOT Analysis 16.14.4. Financial Overview 16.14.5. Strategic Overview 16.16 Optos Plc (UK) (a part of Nikon Corporation) 16.16.1. Company Overview (HQ, Business Segments, Employee Strength) 16.16.2. Product Portfolio 16.16.3. SWOT Analysis 16.16.4. Financial Overview 16.16.5. Strategic Overview 16.16 Kowa Company Ltd. 16.16.1. Company Overview (HQ, Business Segments, Employee Strength) 16.16.2. Product Portfolio 16.16.3. SWOT Analysis 16.16.4. Financial Overview 16.16.5. Strategic Overview
17. Pre and Post COVID-19 Impact 17.1. Positive influence on the healthcare industry 17.2. The financial disruption of the manufacturing sector 17.3. Impact of COVID-19 on emerging companies 17.4. Significant mandates in the regulations initiated by healthcare administrations 17.5. The overall economic slowdown of the developing and developed nations
18. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics